Promoter group members report encumbrance of 12.39 lakh shares

Ownership Changes View source PDF Explain this filing

AARTIDRUGS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.8%Reaction day

₹386.25

prior close

₹379.90

announcement price

In-mkt

timing

Nifty Microcap 250market+0.2%-2.0% vs market

Pharmaceuticals peers, median of 164sector-0.5%-1.3% vs sector

On the reaction day the stock moved 2.0 pts less than Nifty Microcap 250 and 1.3 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.1

10m

+0.0

15m

+0.2

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.8+0.2-2.0-0.5-1.3

Next day

+0.7-0.5+1.2-0.7+1.4

+1.0-2.5+3.5-1.7+2.7

+3.0-0.6+3.6-1.3+4.3

+3.0+0.7+2.2-0.5+3.4

+2.4+0.9+1.5+0.2+2.2

+9.3+0.5+8.8+0.4+8.9

15d

+6.1-0.2+6.4-1.4+7.6

+6.4+2.9+3.5-1.7+8.1

+9.6+5.0+4.6+1.2+8.4

+10.9+3.7+7.2+0.4+10.5

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 164Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Harshit M. Savla, promoter of Aarti Drugs, filed an annual declaration under SEBI Takeover Regulations on April 9, 2026. Two promoter group members - Mirik Rajendra Gogri and Renil Rajendra Gogri - have encumbered 6.41 lakh and 5.98 lakh shares respectively as on March 31, 2026, totaling about 12.39 lakh shares. No other encumbrance was created by the promoter group during FY26.

Likely market impact

Routine annual disclosure of existing share encumbrance by two promoter group entities. No new pledging activity reported during the year.